BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 16041836)

  • 1. Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents.
    Bekircan O; Küxük M; Kahveci B; Kolayli S
    Arch Pharm (Weinheim); 2005 Aug; 338(8):365-72. PubMed ID: 16041836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
    Saczewski F; Bułakowska A
    Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
    Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
    Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
    Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
    Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
    Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
    Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
    Saczewski F; Maruszak M; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, structure and anticancer activity of novel 2,4-diamino-1,3,5-triazine derivatives.
    Saczewski F; Bułakowska A; Bednarski P; Grunert R
    Eur J Med Chem; 2006 Feb; 41(2):219-25. PubMed ID: 16377034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
    Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
    Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new spiroindolinones incorporating a benzothiazole moiety as antioxidant agents.
    Karali N; Güzel O; Ozsoy N; Ozbey S; Salman A
    Eur J Med Chem; 2010 Mar; 45(3):1068-77. PubMed ID: 20045221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticancer activity of novel 2-amino-4-(4-phenylpiperazino)- 1,3,5-triazine derivatives.
    Pomarnacka E; Bednarski P; Grunert R; Reszka P
    Acta Pol Pharm; 2004; 61(6):461-6. PubMed ID: 15794339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents.
    Zhu W; Liu Y; Zhao Y; Wang H; Tan L; Fan W; Gong P
    Arch Pharm (Weinheim); 2012 Oct; 345(10):812-21. PubMed ID: 22707438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of di-phenyl-tin(IV)-salicyliden-ortho-aminophenols: analysis of in vitro antitumor/antioxidant activities and molecular structures.
    Beltrán HI; Damian-Zea C; Hernández-Ortega S; Nieto-Camacho A; Ramírez-Apan MT
    J Inorg Biochem; 2007 Jul; 101(7):1070-85. PubMed ID: 17555822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives.
    Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H
    Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities.
    Nie Z; Perretta C; Erickson P; Margosiak S; Lu J; Averill A; Almassy R; Chu S
    Bioorg Med Chem Lett; 2008 Jan; 18(2):619-23. PubMed ID: 18055206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel amino and acetyl amino-4-methylcoumarins and evaluation of their antioxidant activity.
    Tyagi YK; Kumar A; Raj HG; Vohra P; Gupta G; Kumari R; Kumar P; Gupta RK
    Eur J Med Chem; 2005 Apr; 40(4):413-20. PubMed ID: 15804541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis and antitumor evaluation of 2,4-diamino-6-aryl-1,3,5-triazines.
    Hu Z; Ma T; Chen Z; Ye Z; Zhang G; Lou Y; Yu Y
    J Comb Chem; 2009 Mar; 11(2):267-73. PubMed ID: 19125569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents.
    Bandgar BP; Gawande SS; Bodade RG; Totre JV; Khobragade CN
    Bioorg Med Chem; 2010 Feb; 18(3):1364-70. PubMed ID: 20064725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclocondensation reaction of heterocyclic carbonyl compounds. Part XIII: synthesis and cytotoxic activity of some 3,7-diaryl-5-(3,4,5-trimethoxyphenyl)pyrazolo[4,3-e][1,2,4]triazines.
    Gucký T; Frysová I; Slouka J; Hajdúch M; Dzubák P
    Eur J Med Chem; 2009 Feb; 44(2):891-900. PubMed ID: 18632190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of new spin-labeled derivatives of podophyllotoxin.
    Jin Y; Chen SW; Tian X
    Bioorg Med Chem; 2006 May; 14(9):3062-8. PubMed ID: 16406792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor activity studies of some new fused 1,2,4-triazole derivatives carrying 2,4-dichloro-5-fluorophenyl moiety.
    Bhat KS; Poojary B; Prasad DJ; Naik P; Holla BS
    Eur J Med Chem; 2009 Dec; 44(12):5066-70. PubMed ID: 19822384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.